How Clinical Perinatal Software Struggle in Healthcare Sectors

-

Market Research Future.com add new report of “Clinical Perinatal Software Market Research Report – Global Forecast To 2023” it contains Company information, geographical data and Table of Content

Clinical Perinatal Software Market information: by products (integrated software and standalone software), by services (implementation services and others), by deployment models (on-premises and cloud-based), by applications (Fetal monitor data services and others), and end user - Forecast till 2023
the clinical perinatal software monitor health of fetus and pregnant women. It provides information about any complexity that may arise during the prenatal period, which helps to minimize the problems during the pregnancy.
The Global Clinical Perinatal Software Market is growing at a steady pace and is expected to grow at a CAGR of ~7.2 % during review period 2017-2023. Increasing awareness and a rising birth rate & post-date pregnancy drive the growth of the market. Moreover, increasing healthcare expenditure, continuous development in technology, and increasing government support for research & development likely to boost the demand for the software. On the other hand, complex user interface and high cost of the software may slow the market growth over the assessment period.
Some of the key players in this market: General Electric, Edan Instruments, Inc., Huntleigh Healthcare Limited, KONINKLIJKE PHILIPS N.V, K2 Medical Systems, PeriGen, Inc, Cerner Corporation, Trium Analysis Online, and others.
Clinical Perinatal Software Market has been segmented on the basis of products, which comprises of integrated software and standalone software.
On the basic of services, the market is segmented into implementation services, support & maintenance services, training service, customization services, and online resources.
On the basic of deployed models, the market is segmented on-premises and cloud-based.
On the basis of applications, the market is segmented into fetal monitor data services, workflow management, and patient documentation.
On the basis of end users, it is segmented into hospital & clinics and maternity clinics.
Regional Analysis of the Global Clinical Perinatal Software Market               
The Americas region accounted for a lion share of USD 65.31 million in 2016, owing to the well-developed technology, high healthcare expenditure, and the presence of the leading players.
Europe is the second largest market that holds a noticeable share of the Global Clinical Perinatal Software Market. The European market is expected to grow significantly during the forecast period owing to well-developed healthcare infrastructure and increasing investment in healthcare. Germany, the UK, and France contribute significantly to the growth of the European market.
In Asia Pacific, rising number of hospitals, increasing need for better diagnostic methods, and demand for cost-effective treatment & diagnostics services are the key factors for the market growth.
The Middle East & Africa is expected to show steady growth in this market due to low technology penetration and less availability of innovative healthcare technologies.
Key Findings
The Global Clinical Perinatal Software Market and is expected to reach USD 60 million by 2023.
Integrated software segment on the basis of products holds the largest share of 75.8% of the market.
Americas holds the largest market share of 39.2% of Clinical Perinatal Software Market and is anticipated to reach USD 93 million by the end of the forecast period.
Asia Pacific is the fastest growing region across the globe and expected to grow at a rate of CAGR 7.8% during the forecast period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
     Market Research Future
+1 646 845 9312


Comments

Post a Comment

Popular posts from this blog

Actinic Keratosis Treatment Market Share, Demand, New Opportunities and Foresight to 2024

-
Market Research Future has added a report titled “Actinic Keratosis Treatment Market Research Report- Forecast to 2024” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Report Overview: Rise in the diagnosis efficiency of various types of cancers especially those related to the skin such as actinic keratosis are growing promptly. The treatment of actinic keratosis is gaining increasing prominence due to an extensive range of factors that are contributing to the expansion of the market. Actinic keratosis is a commonly diagnosed skin disorder that can potentially progress to non-melanoma skin cancers, this particular characteristic of the disease has contributed to the demand for its treatment significantly. A typical patient example with actinic keratosis is usually observed as having fair and sun-sensitive skin. Get Premium Copy @  https://www.marketr
Read more

Wearable Medical Device Market Poised for Steady Growth in the Future 2027

-
The Global  Wearable Medical Device   Market  Research   Report provides detailed analysis of the key regional market status of the Healthcare Industry. The  Wearable Medical Device Market  is expected to reach USD 4 billion in the forecasted period. The market is expected to grow at a CAGR of 26.78%. This growth in the market can be due to various factors such as increasing focus on fitness among individuals and awareness about healthy lifestyle. Furthermore signi8ficant growth in the home healthcare is expected to push up the demand for this segment. Top key players in the  wearable Medical Device market  are:  Fitbit Inc., Garmin, Vital Connect, Omron Corp., Sotera Wireless, Jawbone, Pebble Technology Corp., Basis Science Inc., Withings, Intelesens Ltd., Covidien Plc, LifeWatch AG, Polar Electro, Philips Electronics, and Everist Genomics. Get Sample copy at  https://www.marketresearchfuture.com/sample_request/899  . Segments The  Wearable Medical Device Market  can be
Read more

Peripheral Artery Disease Market Will Watch a Sensational Development by 2023: Industry Assertions by MRFR

-
MRFR is the Leading Brand in The Research Company who Recently Published Peripheral Artery Disease Market Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2023. Get Sample Copy @   https://www.marketresearchfuture.com/sample_request/1540 Industry Leading Players: Boston Scientific Corporation, KONINKLIJKE PHILIPS N.V, Abbott, Medtronic, B. Braun Melsungen AG, TERUMO CORPORATION, Becton, Dickinson and Company (BD), Sanofi S.A., Johnson & Johnson Services, Inc., AstraZeneca Plc., Angioscore, Inc., Bristol-Myers Squibb Company, Betagenon AB, Proteon Therapeutics, Inc., Merck & Co., Inc., Bayer HealthCare Pharmaceuticals, Symic Bio, Inc., CardioVascular BioTherapeutics, Inc., AnGes, Inc., TheraVasc Inc., Smith & Nephew plc, Stryker Corporation, Cook Medical, Cordis, Aspen Surgical Products, Inc., Alcon Laboratories, Inc., Zimmer Biomet Holdings, Inc., and others are some of
Read more